The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 04, 2022

Filed:

Oct. 27, 2017
Applicant:

Tarveda Therapeutics, Inc., Watertown, MA (US);

Inventors:

Rajesh R. Shinde, Lexington, MA (US);

Rossitza G. Alargova, Brighton, MA (US);

Patrick Lim Soo, Andover, MA (US);

Beata Sweryda-Krawiec, Marlborough, MA (US);

Leila Alland, Bernardsville, NJ (US);

Christopher Sears, Belmont, MA (US);

Assignee:

TARVEDA THERAPEUTICS, INC., Watertown, MA (US);

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61P 35/00 (2006.01); A61K 47/64 (2017.01); A61K 31/537 (2006.01); A61K 47/14 (2017.01); A61K 47/26 (2006.01); A61K 51/08 (2006.01); C07K 14/72 (2006.01);
U.S. Cl.
CPC ...
A61K 47/64 (2017.08); A61K 31/537 (2013.01); A61K 47/14 (2013.01); A61K 47/26 (2013.01); A61K 51/083 (2013.01); A61P 35/00 (2018.01); C07K 14/72 (2013.01);
Abstract

Conjugates of an active agent such as DM1 attached to a targeting moiety, such as a somatostatin receptor binding moiety, via a linker, and particles comprising such conjugates have been designed. Such conjugates and particles can provide improved temporospatial delivery of the active agent, improved biodistribution and penetration in tumor, and/or decreased toxicity. Methods of making the conjugates, the particles, and the formulations thereof are provided. Methods of administering the formulations to a subject in need thereof are provided, for example, to treat or prevent cancer.


Find Patent Forward Citations

Loading…